Skip to main content

MedAvail Holdings, Inc (MDVL)

NASDAQ: MDVL · IEX Real-Time Price · USD
1.73 -0.01 (-0.57%)
Nov 30, 2021 4:00 PM EST - Market closed

Company Description

MedAvail Holdings, Inc. operates as a technology enabled pharmacy company that embeds automated pharmacy services directly into clinics and other points of care through its proprietary technology.

The company provides turnkey services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations. It also operates SpotRx, a telehealth platform that delivers remote pharmacist consultations through an on-site dispensing kiosk, supplemented with home delivery.

MedAvail Holdings, Inc. is based in Mississauga, Canada.

MedAvail Holdings, Inc
MedAvail Holdings Logo
CountryUnited States
IndustryDrug Manufacturers-Specialty & Generic
SectorHealthcare
Employees224
CEOJoseph Mannello

Contact Details

Address:
45 Horsehill Rd Ste 106
Cedar Knolls, New Jersey 07927-2009
United States
Phone905 812 0023
Websitemedavail.com

Stock Details

Ticker SymbolMDVL
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUS Dollars
CIK Code1402479

Key Executives

NamePosition
Edwin J. KilroyPresident, Chief Executive Officer and Director
Ryan FergusonConsultant
Ramona SeabaughChief Financial Officer
George BurrowsVice President of Operations and Vendor Management
Fraser MackayChief Information Officer
William MisloskiChief Marketing Officer
Lisa LutichVice President of Human Resources
David RawlinsChief Commercial Officer
Joan O'RourkePresident of SpotRx
Brian SchlerfCorporate Controller

Latest SEC Filings

DateTypeTitle
Nov 29, 2021SC 13D/AGeneral statement of acquisition of beneficial ownership
Nov 9, 202110-QQuarterly report [Sections 13 or 15(d)]
Nov 8, 20218-KCurrent report
Oct 25, 20218-KCurrent report
Sep 30, 20218-KCurrent report
Sep 22, 20213Initial statement of beneficial ownership of securities
Sep 20, 20218-KCurrent report
Sep 10, 20218-KCurrent report
Aug 12, 202110-QQuarterly report [Sections 13 or 15(d)]
Aug 11, 20218-KCurrent report
View All SEC Filings